Community Advisory Body
A formal role be given within IBCA for an advisory body consisting of people infected and affected, covering a range of experience broadly representative of those groups, and (if those groups so wish) including clinicians covering the major relevant disciplines of hepatitis and liver disease, HIV, transfusion, haemophilia, psychosocial aspects and palliative care. The advisory body should choose its chair, and the chair should be formally invited to each and every meeting of the Board of IBCA, and be given observer status.
How was this assessed?
Response
Accepted
Response
AcceptedThe remaining 11 recommendations focus on IBCA delivery. Further detail on these will be set out by IBCA in due course.
Progress Timeline
IBCA has established a 13-member Community Advisory Panel chaired by Tim Green (appointed 4 March 2026), comprising people with direct or professional experience of the infected blood scandal. IBCA is also recruiting a Clinical Advisory Panel of seven senior clinicians covering hepatitis, liver disease, HIV, transfusion, haemophilia, psychosocial aspects, and palliative care (recruitment closes 23 March 2026). (Source: IBCA Community Update, 12 March 2026)
Published Evidence
Published assessments of implementation progress from inspectorates, select committees, official progress reports, and other sources. Check the source type badge to see whether each assessment is independent or government self-reported.
As of 13 January 2026: 3,721 people asked to start claims, 3,546 begun process, 3,074 received offers totalling £2.47bn, 2,861 paid totalling £1.89bn. Third compensation regulations in force 31 December 2025.
View detailed findings
IBCA exceeded initial expectations. Three sets of regulations now in force covering infected persons, affected persons, and supplementary routes. £11.8bn committed in October 2024 Budget. Independent review found "very creditable progress."